Specialists are debating calls to employ developmental medicines against an Ebola outbreak ravaging West Africa, the Canadian Press reports.
A number of analysts said distributing vaccines or drug treatments that are not fully tested may boost local distrust of officials that have been fighting the spread of Ebola hemorrhagic fever since March, the news agency reported on Wednesday. No fully vetted medicines currently exist for the disease, which as of Tuesday may have killed more than 500 people in Guinea, Liberia and Sierra Leone.
According to some opponents of using such medicines, any adverse side effects may threaten years of efforts to develop the drugs as a defense against the potential biological-weapon agent.
“It would be unethical to roll [developmental medicines] out now, in my opinion,” said David Heymann, a former World Health Organization assistant director general.
Officials could instead move, once the current threat subsides, to lay the groundwork for using such treatments to combat future outbreaks, Heymann argued. The World Health Organization could make such policy preparations in collaboration with drug developers and regional governments, he said.
One expert, though, pressed for immediately using Ebola countermeasures now in a late stage of development.
“Imagine if you take a region of Canada, America, Europe and you had 450 people dying of a viral hemorrhagic fever. It would just be unacceptable — and it’s unacceptable in West Africa,” said Jeremy Farrar, a tropical medicine and global health specialist at Oxford University.
What We're Following See More »
DC Mayor Muriel Bowser met with Donald Trump this morning in Manhattan, with statehood and the Metro system on the agenda. “We talked about the things that are important to Washingtonians, and certainly becoming the 51st state is one of them," she said after the meeting. She also made the point that the District is “not dependent on the federal government for our funds," and brought up funding for Metro. She told reporters that Trump is a fan of D.C.
"A unanimous Supreme Court on Tuesday sided with smartphone maker Samsung in its high-profile patent dispute with Apple over design of the iPhone. The justices said Samsung may not be required to pay all the profits it earned from 11 phone models because the features at issue are only a tiny part of the devices. Apple had won a $399 million judgment against Samsung for copying parts of the iPhone's patented design, but the case now returns to a lower court to decide what Samsung must pay."
"The Pentagon has buried an internal study that exposed $125 billion in administrative waste in its business operations amid fears Congress would use the findings as an excuse to slash the defense budget, according to interviews and confidential memos obtained by The Washington Post."
Christopher Suprun, a GOP elector from Texas, announced in an op-ed for The New York Times that he will not cast his vote in the electoral college for Donald Trump. This one vote will not keep Trump from getting to the 270 necessary to secure an electoral victory, but stands as a strong statement of rebuke. "I am asked to cast a vote on Dec. 19 for someone who shows daily he is not qualified for the office," Suprun wrote.